Markoff; Lewis

Patent Applications and Registrations

Patent applications and USPTO patent grants for Markoff; Lewis.The latest application filed is for "dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3'-utr of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4".

Company Profile

2.9.6

Markoff; Lewis - Bethesda MD

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Dengue Tetravalent Vaccine Containing A Common 30 Nucleotide Deletion In The 3'-utr Of Dengue Types 1,2,3, And 4, Or Antigenic Chimeric Dengue Viruses 1,2,3, And 4 App 20200392469 - Whitehead; Stephen S. ; et al.	2020-12-17
Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3'-utr of dengue types 1, 2, 3, and 4, or antigenic chimeric dengue viruses 1, 2, 3, and 4 Grant 10,837,003 - Whitehead , et al. November 17, 2	2020-11-17
Dengue Tetravalent Vaccine Containing A Common 30 Nucleotide Deletion In The 3'-utr Of Dengue Types 1, 2, 3, And 4, Or Antigenic Chimeric Dengue Viruses 1, 2, 3, And 4 App 20180010099 - Whitehead; Stephen S. ; et al.	2018-01-11
Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3'-UTR of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4 Grant RE46,641 - Whitehead , et al. December 19, 2	2017-12-19
Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3'-UTR of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4 Grant RE46,631 - Whitehead , et al. December 12, 2	2017-12-12
Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3'-UTR of dengue types 1, 2, 3, and 4, or antigenic chimeric dengue viruses 1, 2, 3, and 4 Grant 9,783,787 - Whitehead , et al. October 10, 2	2017-10-10
Dengue Tetravalent Vaccine Containing A Common 30 Nucleotide Deletion In The 3'-utr Of Dengue Types 1, 2, 3, And 4, Or Antigenic Chimeric Dengue Viruses 1, 2, 3, And 4 App 20130011433 - Whitehead; Stephen S. ; et al.	2013-01-10
Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3'-UTR of dengue types 1, 2, 3, and 4 or antigenic chimeric dengue viruses 1, 2, 3, and 4 Grant 8,075,903 - Whitehead , et al. December 13, 2	2011-12-13
West Nile viruses with mutations in the 3' terminal stem and loop secondary structure for use as live virus vaccines Grant 7,851,194 - Markoff , et al. December 14, 2	2010-12-14
Dengue Tetravalent Vaccine Containing A Common 30 Nucleotide Deletion In The 3' -utr Of Dengue Types 1, 2, 3, And 4 Or Antigenic Chimeric Dengue Viruses 1, 2, 3, And 4 App 20090258036 - Whitehead; Stephen S. ; et al.	2009-10-15
Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3'-UTR of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4 Grant 7,517,531 - Whitehead , et al. April 14, 2	2009-04-14
West Nile Viruses With Mutations In The 3' Terminal Stem And Loop Secondary Structure For Use As Live Virus Vaccines App 20090028900 - Markoff; Lewis ; et al.	2009-01-29
Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3'-UTR of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4 App 20070009552 - Whitehead; Stephen S. ; et al.	2007-01-11
Replication-defective dengue viruses that are replication-defective in mosquitoes for use as vaccines Grant 6,685,948 - Zeng , et al. February 3, 2	2004-02-03

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.